Biomarin Pharmaceutical reported $514.9M in Current Liabilities for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 88.22M 7.11M
Acceleron Pharma XLRN:US $ 57.37M 2.11M
Agios Pharmaceuticals AGIO:US $ 57.9M 2.75M
Alexion Pharmaceuticals ALXN:US $ 1426.2M 198.5M
Alnylam Pharmaceuticals ALNY:US $ 610.66M 56.01M
Amgen AMGN:US $ 14842M 257M
Arena Pharmaceuticals ARNA:US $ 53.36M 11.48M
Bayer BAYN:GR € 28727M 801M
Biogen BIIB:US $ 4211.6M 864.4M
Biomarin Pharmaceutical BMRN:US $ 514.9M 71.55M
Bluebird Bio BLUE:US $ 266.56M 18.79M
Gilead Sciences GILD:US $ 10245M 31M
Gw Pharmaceuticals GWPH:US $ 160.25M 0.44M
Insmed INSM:US $ 112.5M 12.84M
IONIS PHARMACEUT IONS:US $ 218M 75.82M
Moderna Inc MRNA:US 9.96B 1.12B
Neurocrine Biosciences NBIX:US $ 225.9M 13M
Ptc Therapeutics PTCT:US $ 465.26M 174.3M
Puma Biotechnology PBYI:US $ 116.26M 21.64M
Regeneron Pharmaceuticals REGN:US $ 3714.8M 17.6M
Sangamo Biosciences SGMO:US $ 131.9M 5.04M
Sarepta Therapeutics SRPT:US $ 373.44M 51.58M
Seattle Genetics SGEN:US $ 698.43M 264.6M
Ultragenyx Pharmaceutical RARE:US $ 135.93M 8.87M
United Therapeutics UTHR:US $ 320M 8.6M
Vertex Pharmaceuticals VRTX:US $ 1914.26M 77.82M
YTE INCY:US $ 742.71M 82.39M